U.S. High Growth Tech and AI Stocks

Ascendis Pharma

Market Cap: US$9.3b

A biopharmaceutical company, focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.

Travere Therapeutics

Market Cap: US$1.7b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

TG Therapeutics

Market Cap: US$5.8b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Alnylam Pharmaceuticals

Market Cap: US$34.8b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

Lumentum Holdings

Market Cap: US$4.3b

Manufactures and sells optical and photonic products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa.

Alkami Technology

Market Cap: US$2.7b

Provides cloud-based digital banking solutions in the United States.

AVITA Medical

Market Cap: US$230.1m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

TKO Group Holdings

Market Cap: US$25.6b

Operates as a sports and entertainment company.

Super Micro Computer

Market Cap: US$20.3b

Develops and sells high performance server and storage solutions based on modular and open architecture in the United States, Europe, Asia, and internationally.

Clene

Market Cap: US$27.6m

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.

Legend Biotech

Market Cap: US$6.4b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

Alvotech

Market Cap: US$2.9b

Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.

Blueprint Medicines

Market Cap: US$5.7b

A precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally.

Bitdeer Technologies Group

Market Cap: US$1.8b

Operates as a technology company for blockchain and computing.

Core Scientific

Market Cap: US$2.2b

Provides digital asset mining services in the United States.

Applied Optoelectronics

Market Cap: US$823.1m

Designs, manufactures, and sells fiber-optic networking products in the United States, Taiwan, and China.

Palantir Technologies

Market Cap: US$201.3b

Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.

Roadzen

Market Cap: US$71.6m

Operates as an insurance technology company.

SideChannel

Market Cap: US$9.8m

SideChannel, Inc. identifies, develops, and deploys of v solutions in North America.

Aldeyra Therapeutics

Market Cap: US$398.3m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.

Checkpoint Therapeutics

Market Cap: US$197.3m

A clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers in the United States and internationally.

Soleno Therapeutics

Market Cap: US$3.3b

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

OS Therapies

Market Cap: US$34.4m

A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.

SpringWorks Therapeutics

Market Cap: US$3.6b

A commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare diseases and cancer.

Tenaya Therapeutics

Market Cap: US$104.4m

A clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.

Madrigal Pharmaceuticals

Market Cap: US$7.2b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

TruGolf Holdings

Market Cap: US$7.8m

Through its subsidiary, engages in the development and sale of indoor golf simulator hardware under the TruGolf Nevada brand for residential and commercial markets in the United States.

MeiraGTx Holdings

Market Cap: US$578.0m

A clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases.

Smith Micro Software

Market Cap: US$13.0m

Engages in the development and sale of software to enhance the mobile experience to wireless and cable service providers in the Americas, Europe, the Middle East, and Africa.

ARS Pharmaceuticals

Market Cap: US$1.2b

A biopharmaceutical company, develops treatments for severe allergic reactions.

TeraWulf

Market Cap: US$1.0b

Operates as a digital asset technology company in the United States.

Spotify Technology

Market Cap: US$114.9b

Provides audio streaming subscription services worldwide.

Exelixis

Market Cap: US$10.3b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Zscaler

Market Cap: US$32.0b

Operates as a cloud security company worldwide.

Sarepta Therapeutics

Market Cap: US$6.8b

A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

ACADIA Pharmaceuticals

Market Cap: US$2.8b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.